CHM chimeric therapeutics limited

Ann: CHM CDH17 ADVANCES TO DOSE LEVEL 2, page-29

  1. 3,140 Posts.
    lightbulb Created with Sketch. 1751
    It does. So I would assume that the Company has paid for the manufacturing runs with the funds already at hand?

    So why the urgency for a cap raise last week? As @Steini and I have been suggesting - they could easily have announced the results for the CDH-17 and CORE-NK updates and see where the share price went. The VWAP would have been higher allowing for a higher raise price and therefore less dilution.

    And it would also be interesting to see how many oppies would be exercised with them being in the money.

    Perhaps Hopper and his family could start the ball rolling?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $69.39K 17.34M

Buyers (Bids)

No. Vol. Price($)
40 26298938 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 9548291 12
View Market Depth
Last trade - 11.21am 18/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.